Cargando…

Tularemia seroprevalence in humans in the region of the Hittite-Arzawa War (Inner Aegean Region), where the first biological weapon was used 3300 years ago

BACKGROUND/AIM: According to Egyptian records, tularemia emerged in the Canaan region, where it was first identified and spread to Anatolia over the Euphrates. It was used as an active biological weapon for the first time in the Hittite-Arzawa War in 1320–1318 BC. This study aimed to investigate the...

Descripción completa

Detalles Bibliográficos
Autores principales: DAVARCI, İsmail, ERYILDIZ, Canan, PERÇİN RENDERS, Duygu, BERBEROĞLU, Ufuk, GÜRCAN, Şaban
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Scientific and Technological Research Council of Turkey (TUBITAK) 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10388056/
https://www.ncbi.nlm.nih.gov/pubmed/36945928
http://dx.doi.org/10.55730/1300-0144.5586
_version_ 1785082025239117824
author DAVARCI, İsmail
ERYILDIZ, Canan
PERÇİN RENDERS, Duygu
BERBEROĞLU, Ufuk
GÜRCAN, Şaban
author_facet DAVARCI, İsmail
ERYILDIZ, Canan
PERÇİN RENDERS, Duygu
BERBEROĞLU, Ufuk
GÜRCAN, Şaban
author_sort DAVARCI, İsmail
collection PubMed
description BACKGROUND/AIM: According to Egyptian records, tularemia emerged in the Canaan region, where it was first identified and spread to Anatolia over the Euphrates. It was used as an active biological weapon for the first time in the Hittite-Arzawa War in 1320–1318 BC. This study aimed to investigate the seroprevalence of tularemia in the Inner Aegean Region, which is thought to be the region where this war was fought 3300 years ago. MATERIALS AND METHODS: Tularemia seropositivity in humans was investigated in 27 villages/neighborhoods in 3 districts in each of Manisa, Kütahya, and Uşak provinces. Before the study, the participants were informed about the disease via posters, and their blood samples were taken following filling out the questionnaire. Microagglutination tests were performed using in-house tularemia antigen and V plate for serological experiments. Rose-Bengal test was also performed on seropositive sera. RESULTS: Of the total of 410 people, 226 (55.12%) were male. The mean age of the volunteers was 43.72 years. The highest participation was from Kütahya Province. According to the results of the tularemia microagglutination test, seropositivity was detected in 6 cases. It was determined that all of the seropositive volunteers were in Kütahya. When the tularemia antibody titers were examined, seropositivity was determined at 1/20–1/160 titers. No positivity was detected in the Rose-Bengal test for cross-reaction. CONCLUSION: Kütahya has been identified as a risky region in terms of tularemia in the Inner Aegean Region. In order to use the resources in the country economically, first of all, the risk areas in terms of tularemia should be determined by serological studies in all regions. In order to increase awareness about the disease, physicians and filiation teams should be trained in risky areas. Surveillance studies should be conducted to identify and monitor possible sources in areas identified as risky.
format Online
Article
Text
id pubmed-10388056
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Scientific and Technological Research Council of Turkey (TUBITAK)
record_format MEDLINE/PubMed
spelling pubmed-103880562023-08-01 Tularemia seroprevalence in humans in the region of the Hittite-Arzawa War (Inner Aegean Region), where the first biological weapon was used 3300 years ago DAVARCI, İsmail ERYILDIZ, Canan PERÇİN RENDERS, Duygu BERBEROĞLU, Ufuk GÜRCAN, Şaban Turk J Med Sci Research Article BACKGROUND/AIM: According to Egyptian records, tularemia emerged in the Canaan region, where it was first identified and spread to Anatolia over the Euphrates. It was used as an active biological weapon for the first time in the Hittite-Arzawa War in 1320–1318 BC. This study aimed to investigate the seroprevalence of tularemia in the Inner Aegean Region, which is thought to be the region where this war was fought 3300 years ago. MATERIALS AND METHODS: Tularemia seropositivity in humans was investigated in 27 villages/neighborhoods in 3 districts in each of Manisa, Kütahya, and Uşak provinces. Before the study, the participants were informed about the disease via posters, and their blood samples were taken following filling out the questionnaire. Microagglutination tests were performed using in-house tularemia antigen and V plate for serological experiments. Rose-Bengal test was also performed on seropositive sera. RESULTS: Of the total of 410 people, 226 (55.12%) were male. The mean age of the volunteers was 43.72 years. The highest participation was from Kütahya Province. According to the results of the tularemia microagglutination test, seropositivity was detected in 6 cases. It was determined that all of the seropositive volunteers were in Kütahya. When the tularemia antibody titers were examined, seropositivity was determined at 1/20–1/160 titers. No positivity was detected in the Rose-Bengal test for cross-reaction. CONCLUSION: Kütahya has been identified as a risky region in terms of tularemia in the Inner Aegean Region. In order to use the resources in the country economically, first of all, the risk areas in terms of tularemia should be determined by serological studies in all regions. In order to increase awareness about the disease, physicians and filiation teams should be trained in risky areas. Surveillance studies should be conducted to identify and monitor possible sources in areas identified as risky. Scientific and Technological Research Council of Turkey (TUBITAK) 2022-11-03 /pmc/articles/PMC10388056/ /pubmed/36945928 http://dx.doi.org/10.55730/1300-0144.5586 Text en © TÜBİTAK https://creativecommons.org/licenses/by/4.0/This work is licensed under a Creative Commons Attribution 4.0 International License.
spellingShingle Research Article
DAVARCI, İsmail
ERYILDIZ, Canan
PERÇİN RENDERS, Duygu
BERBEROĞLU, Ufuk
GÜRCAN, Şaban
Tularemia seroprevalence in humans in the region of the Hittite-Arzawa War (Inner Aegean Region), where the first biological weapon was used 3300 years ago
title Tularemia seroprevalence in humans in the region of the Hittite-Arzawa War (Inner Aegean Region), where the first biological weapon was used 3300 years ago
title_full Tularemia seroprevalence in humans in the region of the Hittite-Arzawa War (Inner Aegean Region), where the first biological weapon was used 3300 years ago
title_fullStr Tularemia seroprevalence in humans in the region of the Hittite-Arzawa War (Inner Aegean Region), where the first biological weapon was used 3300 years ago
title_full_unstemmed Tularemia seroprevalence in humans in the region of the Hittite-Arzawa War (Inner Aegean Region), where the first biological weapon was used 3300 years ago
title_short Tularemia seroprevalence in humans in the region of the Hittite-Arzawa War (Inner Aegean Region), where the first biological weapon was used 3300 years ago
title_sort tularemia seroprevalence in humans in the region of the hittite-arzawa war (inner aegean region), where the first biological weapon was used 3300 years ago
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10388056/
https://www.ncbi.nlm.nih.gov/pubmed/36945928
http://dx.doi.org/10.55730/1300-0144.5586
work_keys_str_mv AT davarciismail tularemiaseroprevalenceinhumansintheregionofthehittitearzawawarinneraegeanregionwherethefirstbiologicalweaponwasused3300yearsago
AT eryildizcanan tularemiaseroprevalenceinhumansintheregionofthehittitearzawawarinneraegeanregionwherethefirstbiologicalweaponwasused3300yearsago
AT percinrendersduygu tularemiaseroprevalenceinhumansintheregionofthehittitearzawawarinneraegeanregionwherethefirstbiologicalweaponwasused3300yearsago
AT berberogluufuk tularemiaseroprevalenceinhumansintheregionofthehittitearzawawarinneraegeanregionwherethefirstbiologicalweaponwasused3300yearsago
AT gurcansaban tularemiaseroprevalenceinhumansintheregionofthehittitearzawawarinneraegeanregionwherethefirstbiologicalweaponwasused3300yearsago